News

Month Year

Month Year

Nov 10, 2025

Eight out of 10 infants and newborns in Canada have access to RSV prevention with Beyfortus® this season
Nov 6, 2025

Rezurock® now covered in Quebec for people living with chronic graft-versus-host disease (GVHD)
Nov 3, 2025

Dupixent® approved in Canada as targeted therapy for chronic spontaneous urticaria (CSU)
Oct 22, 2025

Dupixent® (dupilumab injection) approved in Canada for adults with inadequately controlled Chronic Obstructive Pulmonary Disease (COPD)
Oct 21, 2025

Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose
Jun 9, 2025

Sanofi Appoints James Guy as Country Lead, Canada and General Manager, Specialty Care
- Photos 1
May 14, 2025

Kevzara® approved in Canada for the treatment of adults with polymyalgia rheumatica (PMR)
May 5, 2025

Health Canada has granted approval for Tzield®, the first and only disease-modifying therapy in autoimmune type 1 diabetes in Canada
Apr 22, 2025

Sarclisa® approved in Canada for patients with newly diagnosed multiple myeloma (NDMM)
Mar 27, 2025

Media Update: Once-weekly ALTUVIIIO® approved in Canada for the treatment of adults, adolescents and children living with hemophilia A

Show per page